Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation.

ABSTRACT:

Background

Benzodiazepines (BZDs) are among the most prescribed sedative hypnotics and among the most misused and abused medications by patients, in parallel with opioids. It is estimated that more than 100 million Benzodiazepine (BZD) prescriptions were written in the United States in 2009. While medically useful, BZDs are potentially dangerous. The co-occurring abuse of opioids and BZD, as well as increases in BZD abuse, tolerance, dependence, and short- and long-term side effects, have prompted a worldwide discussion about the challenging aspects of medically managing the discontinuation of BZDs. Abrupt cessation can cause death. This paper addresses the challenges of medications suggested for the management of BZD discontinuation, their efficacy, the risks of abuse and associat

SUBMITTER: Fluyau D 

PROVIDER: S-EPMC5896864 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature